drugset / Trial / NCT02476890

Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)

NCT02476890

RandomizedCrossoverTriple-blindTreatment

Summary

The primary objective of this study was to assess the effect of a single dose of gefapixant 100 mg on cough reflex sensitivity to various challenge agents (capsaicin, citric acid, adenosine triphosphate \[ATP\], and distilled water) in healthy and chronic cough participants.

Timeline

Start
2015-10-28
Primary completion
2016-10-20
Completion
2016-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefapixant Small molecule 100 mg Oral